Credelio

Product Details

The table identifies the packaged product variants and is not a substitute for veterinary prescribing or the current local label. Dogs must be weighed accurately at the time of product selection.

Credelio dog tablets must not be substituted with Credelio CAT. The dog and cat products have different presentations and species-specific labels.

The manufacturer also markets different count formats internationally. South African retailers commonly list a three-tablet pack, but the supplied box should be checked for the exact count and registration information.

The tablets are not scored, and uniformity of split tablets has not been established. Product handling must follow the complete package instructions.

Active Ingredient

Lotilaner acts against susceptible fleas and ticks within the registered product indication. As a systemic medicine, exposure occurs after parasites feed on the treated dog.

The tablet strengths are designed to support accurate whole-tablet selection across different dog weight ranges. They should not be compared by tablet size alone.

The flavoured formulation may contain pork liver, soy, barley, wheat and lactose according to manufacturer information. Dogs with relevant food allergies require veterinary review.

Do not combine Credelio with another isoxazoline or flea-and-tick medicine unless a veterinarian has reviewed the treatment plan.

Safety and Warnings

• Use only for dogs under the current veterinary label.
• Accurately weigh the dog before product selection.
• Do not use the dog product in cats.
• Keep the tablets in the original blister until required.
• Do not split tablets unless the current label and veterinarian specifically permit it.
• Use caution in dogs with a seizure or neurological history.
• Seek veterinary advice after tremors, incoordination, seizures or another neurological sign.
• The safety in breeding, pregnant or lactating dogs may not be established.
• Keep out of reach of children and other animals.
• Store under the temperature and packaging conditions stated on the box.

Isoxazoline products have been associated with neurological adverse reactions, including tremors, incoordination and seizures. These events have been reported even in dogs without a known previous seizure history.

The most appropriate flea-and-tick product depends on age, weight, health, parasite exposure and other medicines. Veterinary assessment is particularly important for very young, underweight, ill or neurologically affected dogs.

This page intentionally excludes practical administration and monthly scheduling instructions.

Frequently Asked Questions

What is the active ingredient?
Credelio dog tablets contain lotilaner.

How many strengths are available?
The verified dog range includes five strengths from 56.25mg to 900mg.

Why are there different strengths?
The packs are labelled for different dog weight bands and require accurate product selection.

Can a Credelio dog tablet be given to a cat?
No. Credelio CAT is a separate species-specific product.

Can tablets be split?
The manufacturer does not recommend splitting because the tablets are not scored and split-tablet uniformity is not established.

Are neurological warnings relevant?
Yes. Isoxazolines have been associated with tremors, incoordination and seizures.

Is it suitable for breeding dogs?
The manufacturer states that safety in breeding, pregnant or lactating dogs has not been evaluated in some registrations.

Credelio Lotilaner Chewable Tablets for Dogs provide five clearly identified veterinary flea-and-tick strengths that require accurate weighing, whole-tablet selection and professional supervision.